Pak Fah Yeow International Limited
HKSE 0239.HK
Pak Fah Yeow International Limited Capital Expenditure for the year ending December 31, 2023: USD -391.90 K
-
Pak Fah Yeow International Limited Capital Expenditure for the year ending December 31, 2022 was USD -19.97 K, a 81.01% change year over year.
-
Pak Fah Yeow International Limited Capital Expenditure for the year ending December 31, 2021 was USD -105.15 K, a -28.01% change year over year.
-
Pak Fah Yeow International Limited Capital Expenditure for the year ending December 31, 2020 was USD -82.14 K, a -45.81% change year over year.
-
Pak Fah Yeow International Limited Capital Expenditure for the year ending December 31, 2019 was USD -56.33 K, a 65.84% change year over year.
| Date | Capital Expenditure | Free Cash Flow | Depreciation And Amortization | Deferred Income Tax |
|---|
Don’t Miss A Beat
| CEO | Mr. Wee Sean Gan |
| IPO Date | Dec. 18, 1991 |
| Location | Hong Kong |
| Headquarters | 200 Gloucester Road |
| Employees | 101 |
| Sector | Health Care |
| Industries | |
Pak Fah Yeow International Limited, together with its subsidiaries, manufactures, markets, and distributes healthcare products under the Hoe Hin brand name in the People's Republic of China, Hong Kong, Macau, Southeast Asia, North America, the United Kingdom, and internationally. It operates through three segments: Healthcare, Property Investments, and Treasury Investments. The company offers white flower embrocation medicated oils, strain relief products, and ointments under, as well as Fúzai 239, a floral-scented white flower embrocation. In addition, it invests in commercial, industrial, residential, and car park properties; and provides advertising agency services. The company was founded in 1927 and is headquartered in Wan Chai, Hong Kong.
Past 5 years
StockViz Staff
February 4, 2025
Any question? Send us an email